LN-976927
LEVOBUNOLOL , 99.9% , 47141-42-4
Update time: 2023-04-23
PRODUCT Properties
| Melting point: | 209-211°C |
| storage temp. | -20°C Freezer, Under Inert Atmosphere |
| Major Application | pharmaceutical (small molecule) |
| InChI | 1S/C17H25NO3/c1-17(2,3)18-10-12(19)11-21-16-9-5-6-13-14(16)7-4-8-15(13)20/h5-6,9,12,18-19H,4,7-8,10-11H2,1-3H3/t12-/m0/s1 |
| InChIKey | IXHBTMCLRNMKHZ-LBPRGKRZSA-N |
| SMILES | N(C[C@H](O)COc1c2c(ccc1)C(=O)CCC2)C(C)(C)C |
| CAS DataBase Reference | 47141-42-4(CAS DataBase Reference) |
Description and Uses
Levobunolol hydrochloride is an antiglaucoma agent in ophthalmie solutions.
Safety
| Symbol(GHS) |  GHS07 |
| Signal word | Warning |
| Hazard statements | H302 |
| Precautionary statements | P301+P312+P330 |
| WGK Germany | WGK 3 |
| Storage Class | 11 - Combustible Solids |
| Hazard Classifications | Acute Tox. 4 Oral |
| Toxicity | LD50 in male, female rats, mice (mg/kg): 700, 800, 1530, 1220 orally; 25, 28, 78, 84 i.v.; LD50 in male, female hamsters, dogs (mg/kg): 435, 500, 100, 100 orally (Kaplan, 1980) |
